Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Here is Why Growth Investors Should Buy Cenovus (CVE) Now
Here is Why Growth Investors Should Buy Cenovus (CVE) Now

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth

3 Reasons Growth Investors Will Love Enova International (ENVA)
3 Reasons Growth Investors Will Love Enova International (ENVA)

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

3 Reasons Growth Investors Will Love Ryder (R)
3 Reasons Growth Investors Will Love Ryder (R)

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock

SOFI Technologies to Report Q1 Earnings: Here's What to Expect
SOFI Technologies to Report Q1 Earnings: Here's What to Expect

SoFi Technologies, Inc. SOFI is scheduled to report its first-quarter 2026 results on April 29, before the bell.

The company has had an impressive earnings surprise history. Earnings surpassed the

Vertex Gears Up to Report Q1 Earnings: What Investors Can ExpectPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Vertex Gears Up to Report Q1 Earnings: What Investors Can Expect

Vertex Pharmaceuticals VRTX is scheduled to report its first-quarter 2026 results on May 4, after market close. The Zacks Consensus Estimate for the to-be-reported quarter’s revenues is pegged at

LLY Expands Oncology Pipeline With $2.3B Ajax Therapeutics AcquisitionPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
LLY Expands Oncology Pipeline With $2.3B Ajax Therapeutics Acquisition

Eli Lilly and Company LLY announced a definitive agreement to acquire Ajax Therapeutics, a clinical-stage biotech focused on developing next-generation JAK inhibitors for the treatment of

SoFi Technologies Stock Before Q1 Earnings: To Buy or Not to Buy?
SoFi Technologies Stock Before Q1 Earnings: To Buy or Not to Buy?

SoFi Technologies, Inc. SOFI will report its first-quarter 2026 results on April 29, before the bell.

The Zacks Consensus Estimate for earnings in the to-be-reported quarter stands at 12 cents

Waste Connections Stock Gains 3.2% Since Q1 Earnings Beat
Waste Connections Stock Gains 3.2% Since Q1 Earnings Beat

Waste Connections, Inc. WCN reported impressive first-quarter 2026 results, with both earnings and revenues beating the Zacks Consensus Estimate.

WCN’s first-quarter earnings of $1.23 per share beat

AMRX Valuation: What 1.69x Sales Means for InvestorsPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
AMRX Valuation: What 1.69x Sales Means for Investors

Amneal Pharmaceuticals AMRX is coming off a strong 12-month run, but the stock’s valuation still screens as discounted versus key benchmarks. That combination can keep investor attention high

GLW Q1 Earnings Match Estimates, Revenues Beat on Optical Strength
GLW Q1 Earnings Match Estimates, Revenues Beat on Optical Strength

Corning Incorporated GLW reported first-quarter 2026 core earnings of 70 cents per share, up 29.6% year over year and in line with the Zacks Consensus Estimate. Revenues of $4.35 billion increased

AMRX Growth Drivers: Generics, Biosimilars, and CrexontPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
AMRX Growth Drivers: Generics, Biosimilars, and Crexont

Amneal Pharmaceuticals AMRX is leaning into a playbook that can work in multiple market backdrops. The company is pairing steady demand in generics with higher-value opportunities in complex

GM Q1 Earnings Beat Estimates on Tariff Adjustment Benefit
GM Q1 Earnings Beat Estimates on Tariff Adjustment Benefit

General Motors GM delivered first-quarter 2026 adjusted earnings of $3.70 per share, which rose 33% from $2.78 a year ago. The figure topped the Zacks Consensus Estimate of $2.61 by 41.8%. Revenues

Earnings Estimates Moving Higher for RBB (RBB): Time to Buy?
Earnings Estimates Moving Higher for RBB (RBB): Time to Buy?

RBB (RBB) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its

South Korea Tops UK as 8th Largest Stock Market: Investing Via ETFs
South Korea Tops UK as 8th Largest Stock Market: Investing Via ETFs

In a historic shift for global finance, South Korea has officially overtaken the United Kingdom to become the world’s eighth-largest stock market. This milestone achievement was driven by a powerful

Q1 Auto Earnings: Can F, CVNA & 3 More Stocks Top Estimates?Photo, wide shot, wide-angle lens, soft focus,  Car rental company, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-Ew7cRec38UnlyYzs41FVEri5.png?st=2023-12-29T14%3A03%3A41Z&se=2023-12-29T16%3A03%3A41Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-12-29T15%3A03%3A25Z&ske=2023-12-30T15%3A03%3A25Z&sks=b&skv=2021-08-06&sig=vZPI3wL5I%2BC5Zknik6hYtwmYdTdsE1ct/DM1evRA8EI%3D
Q1 Auto Earnings: Can F, CVNA & 3 More Stocks Top Estimates?

The first-quarter reporting season for the Auto-Tires-Trucks space has kicked off, with a mixed start. So far, four S&P 500 players—Tesla, Genuine Parts, General Motors and PACCAR—have announced

J&J Sees Continued MedTech Improvement in Q1, Eyes Better 2026Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
J&J Sees Continued MedTech Improvement in Q1, Eyes Better 2026

Johnson & Johnson's JNJ medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech segment accounts for around 36% of

Amgen to Report Q1 Earnings: Can It Keep the Beat Streak Alive?
Amgen to Report Q1 Earnings: Can It Keep the Beat Streak Alive?

Amgen AMGN will report first-quarter 2026 results on April 30 after market close. In the last reported quarter, the company's earnings beat expectations by 11.13%. The Zacks Consensus Estimate for

Why Sandisk Corporation (SNDK) is Poised to Beat Earnings Estimates Again
Why Sandisk Corporation (SNDK) is Poised to Beat Earnings Estimates Again

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Sandisk

Will Shake Shack (SHAK) Beat Estimates Again in Its Next Earnings Report?
Will Shake Shack (SHAK) Beat Estimates Again in Its Next Earnings Report?

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Shake Shack (SHAK), which belongs to the

Will Redwood Trust (RWT) Beat Estimates Again in Its Next Earnings Report?
Will Redwood Trust (RWT) Beat Estimates Again in Its Next Earnings Report?

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Redwood Trust

Will Red Rock Resorts (RRR) Beat Estimates Again in Its Next Earnings Report?
Will Red Rock Resorts (RRR) Beat Estimates Again in Its Next Earnings Report?

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Red Rock Resorts (RRR), which belongs to

Will Ralliant (RAL) Beat Estimates Again in Its Next Earnings Report?
Will Ralliant (RAL) Beat Estimates Again in Its Next Earnings Report?

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Ralliant (RAL), which belongs to the

Will Ridgepost Capital, Inc. (RPC) Beat Estimates Again in Its Next Earnings Report?
Will Ridgepost Capital, Inc. (RPC) Beat Estimates Again in Its Next Earnings Report?

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Ridgepost Capital, Inc. (RPC), which

Will Permian Resources (PR) Beat Estimates Again in Its Next Earnings Report?
Will Permian Resources (PR) Beat Estimates Again in Its Next Earnings Report?

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Permian Resources (PR), which belongs to

Will Rocket Companies (RKT) Beat Estimates Again in Its Next Earnings Report?
Will Rocket Companies (RKT) Beat Estimates Again in Its Next Earnings Report?

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Rocket Companies (RKT), which belongs to the